Device Medical Device

(Bs3) Intracardiac Und

Payments companies reported to CMS as associated with (Bs3) Intracardiac Und. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$41Kassociated payments (2023-2025)
50clinicians with associated payments
1company reporting

By year

2024 $41K

Payments reported as associated with (Bs3) Intracardiac Und, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Interventional Cardiology $14K
Cardiovascular Disease $13K
Clinical Cardiac Electrophysiology $5,046
Anesthesiology $3,018
Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,121
Pediatric Cardiology $1,280

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with (Bs3) Intracardiac Und

These are the largest totals companies reported as associated with (Bs3) Intracardiac Und. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Markus Scherer Charlotte, NC Cardiovascular Disease $3,757.87
Auroa Badin Columbus, OH Clinical Cardiac Electrophysiology $3,584.41
John De Graft-Johnson Modesto, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,120.74
Abdul Moiz Hafiz Springfield, IL Interventional Cardiology $1,493.27
Szymon Wiernek Scarborough, ME Interventional Cardiology $1,447.24
Maheedhar Gedela Wichita, KS Interventional Cardiology $1,381.84
Ahmad Al Turk Springfield, IL Interventional Cardiology $1,329.53
Jeremy Ringewald Tampa, FL Pediatric Cardiology $1,279.54
Carlos Sanchez Soto Columbus, OH Interventional Cardiology $1,157.96
Neal Duggal Ann Arbor, MI Anesthesiology $1,126.23

Prescribed (Bs3) Intracardiac Und?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.